Founded by the team that discovered the generation of beneficial anti-angiogenic forms of VEGF

Chief Executive Officer

SAB Chairman

Director

Chair

Director

Director

Discovery and Development Consultant, ProPharma Partners Ltd

Chief Operating Officer

Financial Controller

Head of Biology

Professor of Ophthalmology, University of Bristol

Professor of Ophthalmology at Harvard Medical School

Professor of Ophthalmology and Neuroscience at the Johns Hopkins Wilmer Eye Institute

Institute for Ophthalmology and Vision Science, Queen’s University, Belfast

Professor of Ophthalmology at Melbourne University

Director of Research, Global Industries, Bloomberg Intelligence